AbbVie Suit Claims Humira Patent Violations by Boehringer Ingelheim
AbbVie filed a federal lawsuit in Delaware claiming Boehringer Ingelheim is illegally infringing on patents in its development of a Humira biosimilar. Source: Drug Industry Daily
FDA Advisory Committee Backs New Indication for Pfizer’s Xeljanz
An FDA advisory committee voted 10-to-1 Thursday to recommend approval of Pfizer’s Xeljanz (tofacitinib) for treatment of psoriatic arthritis. Source: Drug Industry Daily
Senate Sends FDA User Fee Bill to the President; Approves Federal Right-to-Try Legislation
As one of its last items of business before leaving town for the summer, the Senate overwhelmingly voted to reauthorize the FDA’s user fee agreements through fiscal 2022, completing over…
Zymeworks Appoints Dr. To Its Board Of Directors
Life Sciences Jobs ... Source: BioSpace
Biotech Startup Nabs $9M
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Biotech Startup Indalo Therapeutics Nabs $9M" ALT"Biotech Startup Indalo Therapeutics Nabs $9M"August 3, 2017By Mark Terry, BioSpace.com Breaking News StaffSt. Louis, MO Indalo Therapeutics... Source: BioSpace
Regeneron to Terminate Its Antibody Discovery Pact With Sanofi
Life Sciences Jobs ... Source: BioSpace
Bruker Corporation Announces Acquisition Of Field-Portable Platform For Fast And Universal Immunoassay-Detection Of Bacteria, Viruses And Toxins
Life Sciences Jobs ... Source: BioSpace
- Go to the previous page
- 1
- …
- 364
- 365
- 366
- 367
- 368
- 369
- 370
- …
- 610
- Go to the next page